Literature DB >> 20669024

Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis.

Jinggui Chen1, Qingguo Li, Changjian Wang, Huiyan Zhu, Yingqiang Shi, Guangfa Zhao.   

Abstract

PURPOSE: The optimal timing of surgical resection for synchronous colorectal liver metastases (SCLMs) remains controversial. The aim of this metaanalysis was to compare outcomes between simultaneous resection and staged resection from all published comparative studies in the literature.
MATERIALS AND METHODS: Databases, including PubMed, Embase, Cochrane Library, Ovid, and Web of Science, were searched to identify studies comparing outcomes following simultaneous resection with staged resection for SCLM. The metaanalysis was performed by RevMan 4.2.
RESULTS: Fourteen comparative studies comprising 2,204 patients were identified. Patients undergoing simultaneous resection were found to have similar operative time (weighted mean difference [WMD], -34.19; 95% confidence interval [CI], -81.32-12.95, P = .16) and intraoperative blood loss (WMD, -161.33; 95% CI, -351.45-28.79, P = .10). Shorter hospital stay (WMD, -4.77; 95% CI, -7.26-2.28, P < .01) and lower morbidity rate (odds ratio [OR], 0.71; 95% CI, 0.57-0.88, P = .002) were observed in simultaneous resection group. The survival rate in the simultaneous resection group did not statistically differ with that in the staged resection group at 1 year (OR, 0.77; 95% CI, 0.51-1.16, P = .21), 3 years (OR, 1.12; 95% CI, 0.85-1.47, P = .43), and 5 years (OR, 1.14; 95% CI, 0.86-1.50, P = .37) postresection, respectively.
CONCLUSIONS: Simultaneous resection is safe and efficient in the treatment of patients with SCLM while avoiding a second major operation. In appropriately selected patients, simultaneous resection might be considered as the preferred treatment. Since heterogeneity was detected, caution is needed in interpretation of the results. Better designed, adequately powered studies are required for addressing this issue.

Entities:  

Mesh:

Year:  2010        PMID: 20669024     DOI: 10.1007/s00384-010-1018-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  42 in total

1.  Bringing it all together: Lancet-Cochrane collaborate on systematic reviews.

Authors:  M Clarke; R Horton
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Survival of patients after colonic resection for carcinoma with simultaneous liver metastases.

Authors:  B Cady; D O Monson; N W Swinton
Journal:  Surg Gynecol Obstet       Date:  1970-10

5.  Metastatic patterns in patients with carcinomas of the lower esophagus and upper rectum.

Authors:  L Weiss; A Voit; W W Lane
Journal:  Invasion Metastasis       Date:  1984

6.  Combined colon and hepatic resection for synchronous colorectal liver metastases.

Authors:  S Lyass; G Zamir; I Matot; D Goitein; A Eid; O Jurim
Journal:  J Surg Oncol       Date:  2001-09       Impact factor: 3.454

7.  Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer.

Authors:  Armin Thelen; Sven Jonas; Christoph Benckert; Antonino Spinelli; Enrico Lopez-Hänninen; Birgit Rudolph; Ulf Neumann; Peter Neuhaus
Journal:  Int J Colorectal Dis       Date:  2007-02-21       Impact factor: 2.571

8.  Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations.

Authors:  Ioannis Vassiliou; Nick Arkadopoulos; Theodosios Theodosopoulos; Georgios Fragulidis; Athanasios Marinis; Agathi Kondi-Paphiti; Lazaros Samanides; Andreas Polydorou; Constantinos Gennatas; Dionysios Voros; Vassilios Smyrniotis
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

9.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

Authors:  Robert Martin; Philip Paty; Yuman Fong; Andrew Grace; Alfred Cohen; Ronald DeMatteo; William Jarnagin; Leslie Blumgart
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

10.  Simultaneous versus staged resection for synchronous colorectal cancer liver metastases.

Authors:  Robert C G Martin; Vedra Augenstein; Nathan P Reuter; Charles R Scoggins; Kelly M McMasters
Journal:  J Am Coll Surg       Date:  2009-03-26       Impact factor: 6.113

View more
  35 in total

1.  Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: a propensity score matching analysis.

Authors:  Hadrien Tranchart; David Fuks; Luca Vigano; Stefano Ferretti; François Paye; Go Wakabayashi; Alessandro Ferrero; Brice Gayet; Ibrahim Dagher
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

2.  Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study.

Authors:  Stefano Ferretti; Hadrien Tranchart; Joseph F Buell; Constantino Eretta; Alberto Patriti; Marcello Giuseppe Spampinato; Jung Wook Huh; Luca Vigano; Ho Seong Han; Giuseppe Maria Ettorre; Elio Jovine; Thomas Clark Gamblin; Giulio Belli; Go Wakabayashi; Brice Gayet; Ibrahim Dagher
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

3.  Posthepatectomy liver failure after simultaneous versus staged resection of colorectal cancer and synchronous hepatic metastases.

Authors:  D Patrono; G Paraluppi; M Perino; M Palisi; G Migliaretti; P Berchialla; R Romagnoli; M Salizzoni
Journal:  G Chir       Date:  2014 Mar-Apr

Review 4.  Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives.

Authors:  Markus Rentsch; Tobias Schiergens; Andrej Khandoga; Jens Werner
Journal:  Visc Med       Date:  2016-06-13

5.  Short-term outcomes of simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastases.

Authors:  Akira Inoue; Mamoru Uemura; Hirofumi Yamamoto; Masayuki Hiraki; Atsushi Naito; Takayuki Ogino; Ryoji Nonaka; Junichi Nishimura; Hiroshi Wada; Taishi Hata; Ichiro Takemasa; Hidetoshi Eguchi; Tsunekazu Mizushima; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Int Surg       Date:  2014 Jul-Aug

6.  Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis.

Authors:  Francesco M Polignano; Aaron J Quyn; Pandanaboyana Sanjay; Nikola A Henderson; Iain S Tait
Journal:  Surg Endosc       Date:  2012-03-22       Impact factor: 4.584

Review 7.  Simultaneous laparoscopic resection of primary colorectal cancer and associated liver metastases: a systematic review.

Authors:  R M Lupinacci; W Andraus; L B De Paiva Haddad; L A Carneiro D' Albuquerque; P Herman
Journal:  Tech Coloproctol       Date:  2013-09-21       Impact factor: 3.781

8.  Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.

Authors:  C Lim; A Doussot; M Osseis; F Esposito; C Salloum; J Calderaro; C Tournigand; D Azoulay
Journal:  Clin Transl Oncol       Date:  2018-03-28       Impact factor: 3.405

9.  Intermittent clamping of the hepatic pedicle in simultaneous ultrasonography-guided liver resection and colorectal resection with intestinal anastomosis: is it safe?

Authors:  Emilio De Raffele; Mariateresa Mirarchi; Samuele Vaccari; Dajana Cuicchi; Ferdinando Lecce; Barbara Dalla Via; Bruno Cola
Journal:  Int J Colorectal Dis       Date:  2014-09-04       Impact factor: 2.571

10.  Simultaneous colorectal and hepatic procedures for colorectal cancer result in increased morbidity but equivalent mortality compared with colorectal or hepatic procedures alone: outcomes from the National Surgical Quality Improvement Program.

Authors:  Osama H Hamed; Neil H Bhayani; Gail Ortenzi; Jussuf T Kaifi; Eric T Kimchi; Kevin F Staveley-O'Carroll; Niraj J Gusani
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.